#category	term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
GO Process	GO:0006281	DNA repair	7	497	1.4	3.25e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,FANCA,SETD2,BRCA1,BIVM-ERCC5,ERCC5
GO Process	GO:0035282	Segmentation	4	104	1.84	0.0011	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370	TP53,ATM,BMPR1A,WT1
GO Process	GO:0001756	Somitogenesis	3	64	1.92	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107	TP53,ATM,BMPR1A
GO Process	GO:0006289	Nucleotide-excision repair	3	57	1.97	0.0083	9606.ENSP00000269305,9606.ENSP00000491742,9606.ENSP00000498881	TP53,BIVM-ERCC5,ERCC5
GO Process	GO:0006302	Double-strand break repair	4	204	1.55	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,BRCA1,ERCC5
GO Process	GO:0007507	Heart development	5	548	1.21	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759	TP53,ATM,BMPR1A,WT1,SETD2
GO Process	GO:0007548	Sex differentiation	4	282	1.4	0.0083	9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952	ATM,BMPR1A,WT1,FANCA
GO Process	GO:0008630	Intrinsic apoptotic signaling pathway in response to DNA damage	3	75	1.86	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
GO Process	GO:0009790	Embryo development	6	1049	1.01	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,BMPR1A,WT1,SETD2,BRCA1
GO Process	GO:0009952	Anterior/posterior pattern specification	4	216	1.52	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370	TP53,ATM,BMPR1A,WT1
GO Process	GO:0010628	Positive regulation of gene expression	6	1146	0.97	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,BMPR1A,WT1,SETD2,BRCA1
GO Process	GO:0044773	Mitotic DNA damage checkpoint signaling	3	81	1.82	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
GO Process	GO:0048646	Anatomical structure formation involved in morphogenesis	6	938	1.06	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759	TP53,ATM,GNAS,BMPR1A,WT1,SETD2
GO Process	GO:0051052	Regulation of DNA metabolic process	5	541	1.22	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,WT1,SETD2,BRCA1
GO Process	GO:0051716	Cellular response to stimulus	11	6357	0.49	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,BIVM-ERCC5,ERCC5
GO Process	GO:0060429	Epithelium development	6	1069	1.0	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759	TP53,ATM,GNAS,BMPR1A,WT1,SETD2
GO Process	GO:0071479	Cellular response to ionizing radiation	3	75	1.86	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
GO Process	GO:0090304	Nucleic acid metabolic process	8	2203	0.81	0.0083	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,WT1,FANCA,SETD2,BRCA1,BIVM-ERCC5,ERCC5
GO Process	GO:1902895	Positive regulation of miRNA transcription	3	48	2.05	0.0083	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000368370	TP53,BMPR1A,WT1
GO Process	GO:0043009	Chordate embryonic development	5	654	1.14	0.0087	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,BMPR1A,SETD2,BRCA1
GO Process	GO:2001020	Regulation of response to DNA damage stimulus	4	316	1.36	0.0104	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,SETD2,BRCA1
GO Process	GO:0071214	Cellular response to abiotic stimulus	4	325	1.34	0.0112	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000382423,9606.ENSP00000418960	TP53,ATM,MAP3K1,BRCA1
GO Process	GO:0000724	Double-strand break repair via homologous recombination	3	114	1.67	0.0124	9606.ENSP00000278616,9606.ENSP00000418960,9606.ENSP00000498881	ATM,BRCA1,ERCC5
GO Process	GO:0031058	Positive regulation of histone modification	3	111	1.68	0.0124	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
GO Process	GO:1902749	Regulation of cell cycle G2/M phase transition	3	111	1.68	0.0124	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
GO Process	GO:0010225	Response to UV-C	2	15	2.38	0.0140	9606.ENSP00000269305,9606.ENSP00000498881	TP53,ERCC5
GO Process	GO:0043170	Macromolecule metabolic process	10	5781	0.49	0.0140	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,BIVM-ERCC5,ERCC5
GO Process	GO:0090399	Replicative senescence	2	16	2.35	0.0147	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0022402	Cell cycle process	5	835	1.03	0.0166	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,FANCA,SETD2,BRCA1
GO Process	GO:0048589	Developmental growth	4	412	1.24	0.0176	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107	TP53,ATM,GNAS,BMPR1A
GO Process	GO:0060039	Pericardium development	2	19	2.28	0.0176	9606.ENSP00000368370,9606.ENSP00000386759	WT1,SETD2
GO Process	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	2	20	2.25	0.0185	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0022414	Reproductive process	6	1504	0.85	0.0185	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759	ATM,GNAS,BMPR1A,WT1,FANCA,SETD2
GO Process	GO:0006950	Response to stress	8	3358	0.63	0.0192	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,GNAS,FANCA,SETD2,BRCA1,BIVM-ERCC5,ERCC5
GO Process	GO:0008340	Determination of adult lifespan	2	21	2.23	0.0192	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0009314	Response to radiation	4	444	1.21	0.0192	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,BRCA1,ERCC5
GO Process	GO:0048608	Reproductive structure development	4	436	1.22	0.0192	9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759	ATM,WT1,FANCA,SETD2
GO Process	GO:0007369	Gastrulation	3	167	1.51	0.0227	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000386759	TP53,BMPR1A,SETD2
GO Process	GO:0044030	Regulation of DNA methylation	2	25	2.16	0.0227	9606.ENSP00000368370,9606.ENSP00000418960	WT1,BRCA1
GO Process	GO:0046661	Male sex differentiation	3	168	1.5	0.0227	9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952	BMPR1A,WT1,FANCA
GO Process	GO:1901991	Negative regulation of mitotic cell cycle phase transition	3	167	1.51	0.0227	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
GO Process	GO:0001501	Skeletal system development	4	513	1.14	0.0277	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000386759	TP53,GNAS,BMPR1A,SETD2
GO Process	GO:0003006	Developmental process involved in reproduction	5	1023	0.94	0.0277	9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759	ATM,BMPR1A,WT1,FANCA,SETD2
GO Process	GO:0044237	Cellular metabolic process	10	6568	0.44	0.0277	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,BIVM-ERCC5,ERCC5
GO Process	GO:0048863	Stem cell differentiation	3	183	1.47	0.0277	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000386759	TP53,BMPR1A,SETD2
GO Process	GO:0071480	Cellular response to gamma radiation	2	29	2.09	0.0277	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0006807	Nitrogen compound metabolic process	10	6643	0.43	0.0282	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,BIVM-ERCC5,ERCC5
GO Process	GO:0010165	Response to X-ray	2	31	2.06	0.0283	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0060421	Positive regulation of heart growth	2	32	2.05	0.0297	9606.ENSP00000361107,9606.ENSP00000368370	BMPR1A,WT1
GO Process	GO:1901701	Cellular response to oxygen-containing compound	5	1057	0.93	0.0297	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000418960	TP53,ATM,GNAS,WT1,BRCA1
GO Process	GO:1903047	Mitotic cell cycle process	4	537	1.13	0.0297	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,SETD2,BRCA1
GO Process	GO:0007095	Mitotic G2 DNA damage checkpoint signaling	2	34	2.02	0.0315	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
GO Process	GO:0010033	Response to organic substance	7	2692	0.67	0.0315	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,SETD2,BRCA1
GO Process	GO:0071495	Cellular response to endogenous stimulus	5	1103	0.91	0.0337	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000418960	TP53,GNAS,BMPR1A,WT1,BRCA1
GO Process	GO:0009628	Response to abiotic stimulus	5	1107	0.91	0.0339	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000382423,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,MAP3K1,BRCA1,ERCC5
GO Process	GO:0051239	Regulation of multicellular organismal process	7	2749	0.66	0.0347	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1
GO Process	GO:0071417	Cellular response to organonitrogen compound	4	574	1.1	0.0347	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000418960	TP53,GNAS,WT1,BRCA1
GO Process	GO:0043516	Regulation of DNA damage response, signal transduction by p53 class mediator	2	39	1.96	0.0379	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0048583	Regulation of response to stimulus	8	3931	0.56	0.0380	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,FANCA,MAP3K1,SETD2,BRCA1
GO Process	GO:0008406	Gonad development	3	226	1.38	0.0382	9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000373952	ATM,WT1,FANCA
GO Process	GO:0044238	Primary metabolic process	10	7156	0.4	0.0445	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,BIVM-ERCC5,ERCC5
GO Process	GO:2000378	Negative regulation of reactive oxygen species metabolic process	2	44	1.91	0.0445	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
GO Process	GO:0045926	Negative regulation of growth	3	247	1.34	0.0452	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370	TP53,GNAS,WT1
GO Process	GO:2000772	Regulation of cellular senescence	2	46	1.89	0.0457	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
GO Process	GO:0045944	Positive regulation of transcription by RNA polymerase II	5	1250	0.86	0.0491	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000418960	TP53,ATM,BMPR1A,WT1,BRCA1
GO Process	GO:0071310	Cellular response to organic substance	6	2019	0.73	0.0491	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,BRCA1
GO Component	GO:1990391	DNA repair complex	3	43	2.1	0.0040	9606.ENSP00000278616,9606.ENSP00000418960,9606.ENSP00000498881	ATM,BRCA1,ERCC5
STRING clusters	CL:6147	DNA repair pathways, full network, and HDR through Homologous Recombination (HRR)	5	96	1.97	6.59e-06	9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	ATM,FANCA,BRCA1,BIVM-ERCC5,ERCC5
STRING clusters	CL:6148	Diseases of DNA repair, and DNA repair complex	4	76	1.97	6.20e-05	9606.ENSP00000278616,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	ATM,BRCA1,BIVM-ERCC5,ERCC5
STRING clusters	CL:6280	Nucleotide-excision repair complex, and XPG/Rad2 endonuclease, eukaryotes	2	10	2.55	0.0122	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
STRING clusters	CL:6195	BRCA1-C complex, and NIPBL role in DNA damage - Cornelia de Lange syndrome	2	12	2.47	0.0147	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
KEGG	hsa01524	Platinum drug resistance	3	70	1.89	0.0026	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
KEGG	hsa05206	MicroRNAs in cancer	3	159	1.53	0.0144	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
KEGG	hsa03420	Nucleotide excision repair	2	46	1.89	0.0216	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
KEGG	hsa03440	Homologous recombination	2	38	1.97	0.0216	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
KEGG	hsa03460	Fanconi anemia pathway	2	51	1.85	0.0216	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	3	210	1.41	0.0216	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000382423	TP53,ATM,MAP3K1
KEGG	hsa04115	p53 signaling pathway	2	72	1.7	0.0325	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
KEGG	hsa05165	Human papillomavirus infection	3	324	1.22	0.0325	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141	TP53,ATM,GNAS
KEGG	hsa04912	GnRH signaling pathway	2	87	1.61	0.0403	9606.ENSP00000360141,9606.ENSP00000382423	GNAS,MAP3K1
KEGG	hsa01522	Endocrine resistance	2	94	1.58	0.0422	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Reactome	HSA-73894	DNA Repair	5	310	1.46	0.00098	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,FANCA,BRCA1,ERCC5
Reactome	HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	3	60	1.95	0.0058	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
Reactome	HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	3	62	1.94	0.0058	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
Reactome	HSA-69473	G2/M DNA damage checkpoint	3	77	1.84	0.0058	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
Reactome	HSA-6804756	Regulation of TP53 Activity through Phosphorylation	3	92	1.77	0.0066	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
Reactome	HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	2	12	2.47	0.0084	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	2	26	2.14	0.0169	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	2	19	2.28	0.0169	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-6804760	Regulation of TP53 Activity through Methylation	2	19	2.28	0.0169	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-9701192	Defective homologous recombination repair (HRR) due to BRCA1 loss of function	2	24	2.17	0.0169	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-9704331	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function	2	24	2.17	0.0169	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-9704646	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function	2	24	2.17	0.0169	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-9709603	Impaired BRCA2 binding to PALB2	2	24	2.17	0.0169	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	2	32	2.05	0.0189	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-9709570	Impaired BRCA2 binding to RAD51	2	34	2.02	0.0192	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-6804757	Regulation of TP53 Degradation	2	35	2.01	0.0194	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-5685938	HDR through Single Strand Annealing (SSA)	2	37	1.99	0.0197	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	2	39	1.96	0.0210	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	2	51	1.85	0.0283	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-5693571	Nonhomologous End-Joining (NHEJ)	2	51	1.85	0.0283	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-912446	Meiotic recombination	2	56	1.81	0.0300	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
Reactome	HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	2	60	1.78	0.0333	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP5316	Primary ovarian insufficiency	6	171	1.8	1.67e-07	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960	ATM,GNAS,BMPR1A,WT1,FANCA,BRCA1
WikiPathways	WP3651	Pathways affected in adenoid cystic carcinoma	4	65	2.04	1.74e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,SETD2,BRCA1
WikiPathways	WP4016	DNA IR-damage and cellular response via ATR	4	81	1.95	2.70e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000418960	TP53,ATM,FANCA,BRCA1
WikiPathways	WP4946	DNA repair pathways, full network	4	120	1.78	9.29e-05	9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	ATM,FANCA,BRCA1,ERCC5
WikiPathways	WP2516	ATM signaling pathway	3	40	2.13	0.00025	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP1971	Integrated cancer pathway	3	44	2.09	0.00027	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP5087	Malignant pleural mesothelioma	5	434	1.31	0.00027	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,MAP3K1,SETD2,BRCA1
WikiPathways	WP3959	DNA IR-double strand breaks and cellular response via ATM	3	55	1.99	0.00038	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP1530	miRNA regulation of DNA damage response	3	71	1.88	0.00066	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP707	DNA damage response	3	69	1.89	0.00066	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP2261	Glioblastoma signaling pathways	3	82	1.82	0.00088	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	2	11	2.51	0.0014	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
WikiPathways	WP2263	Androgen receptor network in prostate cancer	3	109	1.69	0.0017	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP5322	CKAP4 signaling pathway map	3	114	1.67	0.0017	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP710	DNA damage response (only ATM dependent)	3	109	1.69	0.0017	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000382423	TP53,ATM,MAP3K1
WikiPathways	WP1545	miRNAs involved in DNA damage response	2	15	2.38	0.0019	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP1742	TP53 network	2	19	2.28	0.0027	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP4262	Breast cancer pathway	3	154	1.54	0.0034	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418960	TP53,ATM,BRCA1
WikiPathways	WP3982	miRNA regulation of p53 pathway in prostate cancer	2	24	2.17	0.0038	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP3646	Hepatitis C and hepatocellular carcinoma	2	48	1.87	0.0133	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
WikiPathways	WP5053	Development of ureteric collection system	2	60	1.78	0.0196	9606.ENSP00000361107,9606.ENSP00000368370	BMPR1A,WT1
WikiPathways	WP45	G1 to S cell cycle control	2	64	1.75	0.0211	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP254	Apoptosis	2	83	1.64	0.0335	9606.ENSP00000269305,9606.ENSP00000382423	TP53,MAP3K1
Monarch	HP:0000008	Abnormal morphology of female internal genitalia	9	355	1.66	1.47e-10	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0000812	Abnormal internal genitalia	9	391	1.62	1.73e-10	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0010460	Abnormality of the female genitalia	9	422	1.58	2.27e-10	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0011793	Neoplasm by anatomical site	10	732	1.39	2.27e-10	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0011792	Neoplasm by histology	8	275	1.72	5.29e-10	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,BMPR1A,WT1,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0010461	Abnormality of the male genitalia	10	951	1.27	1.33e-09	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0000137	Abnormality of the ovary	7	165	1.88	1.67e-09	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,WT1,MAP3K1,SETD2,BRCA1
Monarch	HP:0000135	Hypogonadism	8	343	1.62	2.00e-09	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,WT1,FANCA,MAP3K1,BRCA1,ERCC5
Monarch	HP:0000818	Abnormality of the endocrine system	10	1070	1.22	2.99e-09	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0000080	Abnormality of reproductive system physiology	9	659	1.39	3.21e-09	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0000035	Abnormal testis morphology	9	793	1.31	1.40e-08	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0010787	Genital neoplasm	6	118	1.96	2.15e-08	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,BMPR1A,WT1,MAP3K1,SETD2,BRCA1
Monarch	HP:0010785	Gonadal neoplasm	5	76	2.07	2.86e-07	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,WT1,MAP3K1,SETD2,BRCA1
Monarch	HP:0001824	Weight loss	6	218	1.69	5.16e-07	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,WT1,FANCA,BRCA1,ERCC5
Monarch	HP:0000119	Abnormality of the genitourinary system	10	2189	0.91	1.56e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0001507	Growth abnormality	10	2182	0.91	1.56e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0030012	Abnormal female reproductive system physiology	6	273	1.6	1.69e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759	TP53,ATM,GNAS,WT1,MAP3K1,SETD2
Monarch	HP:0032251	Abnormal immune system morphology	7	545	1.36	1.90e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,FANCA,SETD2,BRCA1
Monarch	HP:0100728	Germ cell neoplasia	4	35	2.31	2.01e-06	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759	TP53,WT1,MAP3K1,SETD2
Monarch	HP:0004323	Abnormality of body weight	9	1513	1.03	2.06e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0001510	Growth delay	9	1525	1.02	2.13e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0031065	Abnormal ovarian morphology	5	125	1.86	2.18e-06	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759	ATM,GNAS,WT1,MAP3K1,SETD2
Monarch	HP:0000953	Hyperpigmentation of the skin	6	297	1.56	2.21e-06	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0033019	Male reproductive system neoplasm	4	41	2.24	3.04e-06	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000382423,9606.ENSP00000418960	TP53,BMPR1A,MAP3K1,BRCA1
Monarch	HP:0001626	Abnormality of the cardiovascular system	10	2438	0.87	3.20e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0002012	Abnormality of the abdominal organs	8	1068	1.13	4.05e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1
Monarch	HP:0002597	Abnormality of the vasculature	9	1673	0.98	4.05e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0002715	Abnormality of the immune system	9	1682	0.98	4.05e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0011842	Abnormal skeletal morphology	10	2573	0.84	4.84e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0045058	Abnormality of the testis size	5	161	1.75	5.83e-06	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,MAP3K1,BRCA1,ERCC5
Monarch	HP:0100615	Ovarian neoplasm	4	52	2.14	6.10e-06	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000418960	TP53,WT1,MAP3K1,BRCA1
Monarch	HP:0003002	Breast carcinoma	4	54	2.12	6.86e-06	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000418960	TP53,ATM,GNAS,BRCA1
Monarch	HP:0000815	Hypergonadotropic hypogonadism	4	56	2.11	7.50e-06	9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423	GNAS,WT1,FANCA,MAP3K1
Monarch	HP:0000138	Ovarian cyst	4	57	2.1	7.83e-06	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000382423,9606.ENSP00000386759	ATM,GNAS,MAP3K1,SETD2
Monarch	HP:0002898	Embryonal neoplasm	4	61	2.07	9.91e-06	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759	TP53,WT1,MAP3K1,SETD2
Monarch	HP:0001034	Hypermelanotic macule	5	194	1.66	1.18e-05	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,FANCA,BRCA1,ERCC5
Monarch	HP:0004325	Decreased body weight	8	1274	1.05	1.18e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,BRCA1,ERCC5
Monarch	HP:0033353	Abnormal blood vessel morphology	7	792	1.2	1.30e-05	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0010978	Abnormality of immune system physiology	8	1347	1.03	1.60e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0011354	Generalized abnormality of skin	7	821	1.18	1.60e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,FANCA,SETD2,ERCC5
Monarch	HP:0012372	Abnormal eye morphology	9	2077	0.89	1.73e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0007378	Neoplasm of the gastrointestinal tract	5	221	1.61	1.90e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000418960	TP53,GNAS,BMPR1A,WT1,BRCA1
Monarch	HP:0011024	Abnormality of the gastrointestinal tract	8	1384	1.02	1.90e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1
Monarch	HP:0000140	Abnormality of the menstrual cycle	5	228	1.59	2.14e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759	TP53,GNAS,WT1,MAP3K1,SETD2
Monarch	HP:0004377	Hematological neoplasm	5	232	1.59	2.25e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,FANCA,SETD2,BRCA1
Monarch	HP:0001939	Abnormality of metabolism/homeostasis	9	2168	0.87	2.26e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0033127	Abnormality of the musculoskeletal system	10	3173	0.75	2.32e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0001392	Abnormality of the liver	7	895	1.15	2.35e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1
Monarch	HP:0009121	Abnormal axial skeleton morphology	9	2206	0.86	2.51e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000366	Abnormality of the nose	8	1470	0.99	2.60e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000144	Decreased fertility	5	245	1.56	2.65e-05	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0001881	Abnormal leukocyte morphology	6	517	1.32	2.67e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,FANCA,SETD2,BRCA1
Monarch	HP:0010987	Abnormal cellular immune system morphology	6	517	1.32	2.67e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,FANCA,SETD2,BRCA1
Monarch	HP:0011277	Abnormality of the urinary system physiology	7	933	1.13	2.80e-05	9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0012443	Abnormality of brain morphology	9	2254	0.85	2.80e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0001574	Abnormality of the integument	9	2266	0.85	2.84e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0012125	Prostate cancer	3	18	2.47	3.02e-05	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000418960	TP53,BMPR1A,BRCA1
Monarch	HP:0012378	Fatigue	5	258	1.54	3.03e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,ERCC5
Monarch	HP:0012211	Abnormal renal physiology	6	560	1.28	3.78e-05	9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,WT1,FANCA,MAP3K1,SETD2,BRCA1
Monarch	EFO:0003765	Sign or symptom	6	573	1.27	4.21e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,ERCC5
Monarch	HP:0025031	Abnormality of the digestive system	9	2389	0.83	4.21e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000707	Abnormality of the nervous system	10	3471	0.71	4.33e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0002086	Abnormality of the respiratory system	8	1636	0.94	4.67e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1
Monarch	HP:0011121	Abnormality of skin morphology	8	1648	0.94	4.88e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000079	Abnormality of the urinary system	8	1657	0.94	5.03e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0008669	Abnormal spermatogenesis	4	112	1.81	5.42e-05	9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000418960	ATM,FANCA,MAP3K1,BRCA1
Monarch	HP:0030680	Abnormality of cardiovascular system morphology	8	1680	0.93	5.46e-05	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0012252	Abnormal respiratory system morphology	7	1067	1.07	5.53e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,BMPR1A,WT1,FANCA,SETD2,BRCA1
Monarch	HP:0000028	Cryptorchidism	6	619	1.24	5.75e-05	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0000077	Abnormality of the kidney	7	1077	1.07	5.75e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,GNAS,WT1,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0012639	Abnormal nervous system morphology	9	2546	0.8	6.15e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0000864	Abnormality of the hypothalamus-pituitary axis	5	314	1.46	6.37e-05	9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000418960	GNAS,WT1,FANCA,MAP3K1,BRCA1
Monarch	HP:0010935	Abnormality of the upper urinary tract	7	1101	1.06	6.45e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,GNAS,WT1,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0003330	Abnormal bone structure	6	639	1.23	6.53e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,GNAS,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0000927	Abnormality of skeletal maturation	5	327	1.44	7.50e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000498881	TP53,GNAS,MAP3K1,SETD2,ERCC5
Monarch	HP:0031093	Abnormal breast morphology	5	332	1.43	7.99e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000382423,9606.ENSP00000418960	TP53,ATM,GNAS,MAP3K1,BRCA1
Monarch	HP:0100006	Neoplasm of the central nervous system	4	128	1.75	8.02e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000386759	TP53,GNAS,BMPR1A,SETD2
Monarch	HP:0004322	Short stature	7	1152	1.04	8.21e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0002242	Abnormal intestine morphology	6	673	1.2	8.28e-05	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,GNAS,BMPR1A,FANCA,SETD2,BRCA1
Monarch	HP:0100587	Abnormal preputium morphology	3	30	2.25	8.79e-05	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0100579	Mucosal telangiectasiae	3	32	2.23	0.00010	9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000498881	ATM,BMPR1A,ERCC5
Monarch	HP:0001871	Abnormality of blood and blood-forming tissues	7	1214	1.01	0.00011	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,FANCA,SETD2,BRCA1
Monarch	HP:0001909	Leukemia	4	141	1.71	0.00011	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000386759	TP53,ATM,FANCA,SETD2
Monarch	HP:0002667	Nephroblastoma	3	33	2.21	0.00011	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000382423	TP53,WT1,MAP3K1
Monarch	HP:0030669	Abnormal ocular adnexa morphology	7	1218	1.01	0.00011	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0100543	Cognitive impairment	8	1903	0.88	0.00011	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0010468	Aplasia/Hypoplasia of the testes	4	146	1.69	0.00012	9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000418960,9606.ENSP00000498881	FANCA,MAP3K1,BRCA1,ERCC5
Monarch	HP:0000002	Abnormality of body height	7	1253	1.0	0.00013	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000929	Abnormal skull morphology	8	1954	0.87	0.00013	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0012337	Abnormal homeostasis	7	1275	0.99	0.00014	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,SETD2,ERCC5
Monarch	HP:0002118	Abnormal cerebral ventricle morphology	6	765	1.15	0.00015	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0003549	Abnormality of connective tissue	7	1294	0.99	0.00015	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0011004	Abnormal systemic arterial morphology	5	398	1.35	0.00015	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0100526	Neoplasm of the lung	3	43	2.1	0.00020	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000386759	TP53,WT1,SETD2
Monarch	HP:0001010	Hypopigmentation of the skin	4	174	1.61	0.00021	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0011276	Vascular skin abnormality	5	433	1.32	0.00022	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000498881	ATM,GNAS,BMPR1A,FANCA,ERCC5
Monarch	HP:0100790	Hernia	5	435	1.31	0.00023	9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	BMPR1A,WT1,FANCA,SETD2,BRCA1
Monarch	HP:0000969	Edema	5	448	1.3	0.00025	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000498881	TP53,BMPR1A,WT1,SETD2,ERCC5
Monarch	HP:0025033	Abnormality of digestive system morphology	6	849	1.1	0.00025	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,GNAS,BMPR1A,FANCA,SETD2,BRCA1
Monarch	HP:0000147	Polycystic ovaries	3	48	2.05	0.00026	9606.ENSP00000278616,9606.ENSP00000382423,9606.ENSP00000386759	ATM,MAP3K1,SETD2
Monarch	HP:0003220	Abnormality of chromosome stability	3	49	2.04	0.00027	9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000418960	ATM,FANCA,BRCA1
Monarch	HP:0012638	Abnormal nervous system physiology	9	3154	0.71	0.00027	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0011458	Abdominal symptom	7	1448	0.94	0.00028	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,SETD2,ERCC5
Monarch	HP:0002813	Abnormality of limb bone morphology	7	1459	0.93	0.00029	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0002894	Neoplasm of the pancreas	3	52	2.01	0.00031	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000418960	TP53,BMPR1A,BRCA1
Monarch	HP:0011017	Abnormal cellular physiology	5	473	1.28	0.00031	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,FANCA,BRCA1,ERCC5
Monarch	HP:0000486	Strabismus	6	903	1.08	0.00032	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0001367	Abnormal joint morphology	6	905	1.07	0.00032	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0025142	Constitutional symptom	6	906	1.07	0.00032	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,ERCC5
Monarch	HP:0200008	Intestinal polyposis	3	53	2.01	0.00032	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107	TP53,GNAS,BMPR1A
Monarch	HP:0100026	Arteriovenous malformation	3	54	2.0	0.00033	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000418960	BMPR1A,FANCA,BRCA1
Monarch	EFO:0004632	Nevus count	3	57	1.97	0.00037	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000373952	TP53,ATM,FANCA
Monarch	HP:0000639	Nystagmus	6	936	1.06	0.00037	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0012547	Abnormal involuntary eye movements	6	943	1.06	0.00038	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0007565	Multiple cafe-au-lait spots	3	60	1.95	0.00042	9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000418960	ATM,FANCA,BRCA1
Monarch	HP:0002861	Melanoma	3	61	1.94	0.00043	9606.ENSP00000269305,9606.ENSP00000418960,9606.ENSP00000498881	TP53,BRCA1,ERCC5
Monarch	HP:0001732	Abnormality of the pancreas	4	225	1.5	0.00045	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000418960	TP53,GNAS,BMPR1A,BRCA1
Monarch	HP:0002143	Abnormality of the spinal cord	4	225	1.5	0.00045	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,FANCA,SETD2,BRCA1
Monarch	HP:0001167	Abnormality of finger	6	980	1.04	0.00046	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0012531	Pain	5	539	1.22	0.00050	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000498881	TP53,GNAS,BMPR1A,WT1,ERCC5
Monarch	HP:0001945	Fever	4	238	1.48	0.00053	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000498881	TP53,ATM,WT1,ERCC5
Monarch	HP:0011849	Abnormal bone ossification	5	558	1.21	0.00058	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0001643	Patent ductus arteriosus	4	246	1.46	0.00060	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	WT1,FANCA,SETD2,BRCA1
Monarch	HP:0001595	Abnormal hair morphology	6	1040	1.01	0.00062	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	HP:0010929	Abnormal blood cation concentration	4	250	1.46	0.00063	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000386759	TP53,GNAS,BMPR1A,SETD2
Monarch	HP:0002823	Abnormality of femur morphology	4	253	1.45	0.00066	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	TP53,GNAS,FANCA,BRCA1
Monarch	HP:0011821	Abnormal facial skeleton morphology	6	1056	1.01	0.00066	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000036	Abnormal penis morphology	5	592	1.18	0.00075	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	WT1,FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0001017	Anemic pallor	2	7	2.71	0.00076	9606.ENSP00000361107,9606.ENSP00000373952	BMPR1A,FANCA
Monarch	HP:0100835	Benign neoplasm of the central nervous system	3	78	1.84	0.00080	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107	TP53,GNAS,BMPR1A
Monarch	HP:0025032	Abnormality of digestive system physiology	7	1763	0.85	0.00082	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,SETD2,ERCC5
Monarch	HP:0004328	Abnormal anterior eye segment morphology	6	1106	0.99	0.00084	9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,WT1,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0012732	Anorectal anomaly	4	274	1.42	0.00086	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000418960	TP53,BMPR1A,FANCA,BRCA1
Monarch	HP:0010514	Hyperpituitarism	3	82	1.82	0.00088	9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000382423	GNAS,WT1,MAP3K1
Monarch	HP:0000083	Renal insufficiency	4	285	1.4	0.00097	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	WT1,FANCA,SETD2,BRCA1
Monarch	HP:0000047	Hypospadias	4	290	1.39	0.0010	9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,MAP3K1,SETD2,BRCA1
Monarch	HP:0000518	Cataract	5	642	1.14	0.0010	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0001679	Abnormal aortic morphology	4	292	1.39	0.0010	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	WT1,FANCA,SETD2,BRCA1
Monarch	HP:0000142	Abnormal vagina morphology	3	90	1.78	0.0011	9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000382423	BMPR1A,WT1,MAP3K1
Monarch	HP:0000149	Ovarian gonadoblastoma	2	9	2.6	0.0011	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0040069	Abnormal lower limb bone morphology	5	648	1.14	0.0011	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,FANCA,BRCA1,ERCC5
Monarch	HP:0000027	Azoospermia	3	93	1.76	0.0012	9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000418960	FANCA,MAP3K1,BRCA1
Monarch	HP:0000481	Abnormal cornea morphology	5	673	1.12	0.0012	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0004363	Abnormal circulating calcium concentration	3	95	1.75	0.0012	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000386759	TP53,GNAS,SETD2
Monarch	HP:0032263	Increased blood pressure	4	303	1.37	0.0012	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370	TP53,GNAS,BMPR1A,WT1
Monarch	HP:0033799	Abnormal circulating sex hormone concentration	3	93	1.76	0.0012	9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000382423	GNAS,WT1,MAP3K1
Monarch	HP:0002863	Myelodysplasia	3	98	1.74	0.0013	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000418960	TP53,FANCA,BRCA1
Monarch	HP:0002896	Neoplasm of the liver	3	96	1.75	0.0013	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370	TP53,GNAS,WT1
Monarch	HP:0008053	Aplasia/Hypoplasia of the iris	3	96	1.75	0.0013	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960	WT1,FANCA,BRCA1
Monarch	HP:0011362	Abnormal hair quantity	5	682	1.12	0.0013	9606.ENSP00000360141,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,MAP3K1,SETD2,BRCA1,ERCC5
Monarch	EFO:0007989	Monocyte percentage of leukocytes	4	330	1.34	0.0015	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,FANCA,SETD2,BRCA1
Monarch	HP:0000820	Abnormality of the thyroid gland	4	327	1.34	0.0015	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000386759	TP53,GNAS,BMPR1A,SETD2
Monarch	HP:0001053	Hypopigmented skin patches	3	102	1.72	0.0015	9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	FANCA,BRCA1,ERCC5
Monarch	HP:0007376	Abnormal choroid plexus morphology	2	12	2.47	0.0016	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Monarch	HP:0000238	Hydrocephalus	4	345	1.32	0.0017	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	TP53,FANCA,BRCA1,ERCC5
Monarch	EFO:0003843	Pain	4	356	1.3	0.0018	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370	TP53,GNAS,BMPR1A,WT1
Monarch	EFO:0004554	Genomic measurement	3	116	1.67	0.0018	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141	TP53,ATM,GNAS
Monarch	HP:0000240	Abnormality of skull size	6	1333	0.91	0.0018	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000324	Facial asymmetry	3	116	1.67	0.0018	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	GNAS,FANCA,BRCA1
Monarch	HP:0001155	Abnormality of the hand	6	1312	0.91	0.0018	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0001631	Atrial septal defect	4	353	1.31	0.0018	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	WT1,FANCA,SETD2,BRCA1
Monarch	HP:0001872	Abnormality of thrombocytes	4	351	1.31	0.0018	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	TP53,GNAS,FANCA,BRCA1
Monarch	HP:0002251	Aganglionic megacolon	3	113	1.68	0.0018	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0002683	Abnormal calvaria morphology	5	762	1.07	0.0018	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0004362	Abnormality of enteric ganglion morphology	3	113	1.68	0.0018	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0010927	Abnormal blood inorganic cation concentration	3	113	1.68	0.0018	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000386759	TP53,GNAS,SETD2
Monarch	HP:0012050	Anasarca	2	14	2.41	0.0018	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0032101	Unusual infection	5	748	1.08	0.0018	9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	ATM,BMPR1A,FANCA,SETD2,BRCA1
Monarch	HP:0100568	Neoplasm of the endocrine system	3	114	1.67	0.0018	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107	TP53,GNAS,BMPR1A
Monarch	EFO:0010574	Epithelial cell adhesion molecule measurement	2	15	2.38	0.0020	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
Monarch	HP:0008056	Aplasia/Hypoplasia affecting the eye	4	367	1.29	0.0020	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	WT1,FANCA,BRCA1,ERCC5
Monarch	HP:0011603	Congenital malformation of the great arteries	4	371	1.29	0.0020	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	WT1,FANCA,SETD2,BRCA1
Monarch	HP:0011893	Abnormal leukocyte count	4	367	1.29	0.0020	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	ATM,GNAS,FANCA,BRCA1
Monarch	HP:0031105	Abnormal uterus morphology	3	119	1.65	0.0020	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000418960	BMPR1A,FANCA,BRCA1
Monarch	HP:0000502	Abnormal conjunctiva morphology	3	122	1.64	0.0021	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000498881	ATM,GNAS,ERCC5
Monarch	EFO:0004747	Protein measurement	10	5856	0.49	0.0023	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,BIVM-ERCC5,ERCC5
Monarch	HP:0001636	Tetralogy of Fallot	3	128	1.62	0.0024	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960	WT1,FANCA,BRCA1
Monarch	HP:0025633	Abnormal ureter morphology	3	129	1.62	0.0024	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0003254	Abnormality of DNA repair	2	17	2.32	0.0025	9606.ENSP00000373952,9606.ENSP00000498881	FANCA,ERCC5
Monarch	HP:0012041	Decreased fertility in males	3	133	1.61	0.0026	9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000418960	FANCA,MAP3K1,BRCA1
Monarch	HP:0005550	Chronic lymphatic leukemia	2	18	2.3	0.0027	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0009592	Astrocytoma	2	18	2.3	0.0027	9606.ENSP00000269305,9606.ENSP00000386759	TP53,SETD2
Monarch	HP:0011027	Abnormal fallopian tube morphology	2	18	2.3	0.0027	9606.ENSP00000368370,9606.ENSP00000418960	WT1,BRCA1
Monarch	HP:0011772	Abnormal thyroid morphology	3	136	1.6	0.0027	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107	TP53,GNAS,BMPR1A
Monarch	HP:0012210	Abnormal renal morphology	5	837	1.03	0.0027	9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,WT1,FANCA,SETD2,BRCA1
Monarch	HP:0001892	Abnormal bleeding	4	411	1.24	0.0028	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952	TP53,GNAS,BMPR1A,FANCA
Monarch	HP:0004349	Reduced bone mineral density	4	413	1.24	0.0028	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000418960	GNAS,FANCA,MAP3K1,BRCA1
Monarch	HP:0001217	Clubbing	3	143	1.57	0.0031	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000418960	BMPR1A,FANCA,BRCA1
Monarch	HP:0012189	Hodgkin lymphoma	2	20	2.25	0.0031	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0100242	Sarcoma	3	144	1.57	0.0031	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107	TP53,GNAS,BMPR1A
Monarch	HP:0100542	Abnormal localization of kidney	3	144	1.57	0.0031	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960	WT1,FANCA,BRCA1
Monarch	HP:0002814	Abnormality of the lower limb	6	1506	0.85	0.0032	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0012759	Neurodevelopmental abnormality	7	2323	0.73	0.0033	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000524	Conjunctival telangiectasia	2	21	2.23	0.0034	9606.ENSP00000278616,9606.ENSP00000498881	ATM,ERCC5
Monarch	HP:0002088	Abnormal lung morphology	5	893	1.0	0.0034	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759	TP53,ATM,BMPR1A,WT1,SETD2
Monarch	HP:0002031	Abnormal esophagus morphology	3	153	1.55	0.0036	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000418960	TP53,FANCA,BRCA1
Monarch	HP:0200063	Colorectal polyposis	2	22	2.21	0.0036	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0000268	Dolichocephaly	3	158	1.53	0.0039	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0000290	Abnormality of the forehead	5	926	0.99	0.0039	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0005522	Pyridoxine-responsive sideroblastic anemia	2	23	2.19	0.0039	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0012373	Abnormal eye physiology	7	2405	0.72	0.0040	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0005561	Abnormality of bone marrow cell morphology	3	161	1.52	0.0041	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952	ATM,GNAS,FANCA
Monarch	HP:0001508	Failure to thrive	5	949	0.97	0.0043	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,BMPR1A,BRCA1,ERCC5
Monarch	HP:0001511	Intrauterine growth retardation	4	469	1.18	0.0043	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,BRCA1,ERCC5
Monarch	HP:0010293	Aplasia/Hypoplasia of the uvula	2	25	2.16	0.0045	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0010464	Streak ovary	2	25	2.16	0.0045	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0010469	Absent testis	2	25	2.16	0.0045	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0000834	Abnormality of the adrenal glands	3	169	1.5	0.0046	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000382423	TP53,GNAS,MAP3K1
Monarch	HP:0008065	Aplasia/Hypoplasia of the skin	3	170	1.5	0.0046	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000498881	ATM,GNAS,ERCC5
Monarch	HP:0001007	Hirsutism	3	172	1.49	0.0047	9606.ENSP00000360141,9606.ENSP00000382423,9606.ENSP00000386759	GNAS,MAP3K1,SETD2
Monarch	HP:0002027	Abdominal pain	3	172	1.49	0.0047	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000368370	TP53,BMPR1A,WT1
Monarch	HP:0010788	Testicular neoplasm	2	26	2.14	0.0047	9606.ENSP00000269305,9606.ENSP00000382423	TP53,MAP3K1
Monarch	HP:0001999	Abnormal facial shape	5	978	0.96	0.0048	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,BMPR1A,FANCA,SETD2,BRCA1
Monarch	HP:0012649	Increased inflammatory response	5	981	0.96	0.0048	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,SETD2,ERCC5
Monarch	HP:0001249	Intellectual disability	6	1656	0.81	0.0049	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0008069	Neoplasm of the skin	3	175	1.49	0.0049	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000498881	TP53,GNAS,ERCC5
Monarch	HP:0012126	Stomach cancer	2	27	2.12	0.0049	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0000505	Visual impairment	5	995	0.95	0.0051	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,FANCA,BRCA1,ERCC5
Monarch	HP:0001903	Anemia	4	498	1.16	0.0051	9606.ENSP00000269305,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000418960	TP53,BMPR1A,FANCA,BRCA1
Monarch	HP:0000858	Irregular menstruation	2	28	2.11	0.0052	9606.ENSP00000360141,9606.ENSP00000386759	GNAS,SETD2
Monarch	HP:0032180	Abnormal circulating metabolite concentration	5	1010	0.95	0.0054	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000386759	TP53,ATM,GNAS,BMPR1A,SETD2
Monarch	HP:0012539	Non-Hodgkin lymphoma	2	29	2.09	0.0055	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0100867	Duodenal stenosis	2	29	2.09	0.0055	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0009602	Abnormality of thumb phalanx	3	188	1.46	0.0058	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	GNAS,FANCA,BRCA1
Monarch	HP:0040012	Chromosome breakage	2	30	2.08	0.0058	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0100760	Clubbing of toes	2	30	2.08	0.0058	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0004493	Craniofacial hyperostosis	2	31	2.06	0.0060	9606.ENSP00000360141,9606.ENSP00000498881	GNAS,ERCC5
Monarch	HP:0006721	Acute lymphoblastic leukemia	2	31	2.06	0.0060	9606.ENSP00000269305,9606.ENSP00000386759	TP53,SETD2
Monarch	HP:0011014	Abnormal glucose homeostasis	4	527	1.13	0.0060	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000386759	TP53,ATM,GNAS,SETD2
Monarch	HP:0031826	Abnormal reflex	5	1046	0.93	0.0061	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,FANCA,BRCA1,ERCC5
Monarch	HP:0000492	Abnormal eyelid morphology	5	1058	0.93	0.0063	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0100022	Abnormality of movement	6	1758	0.79	0.0063	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0002060	Abnormal cerebral morphology	6	1786	0.78	0.0069	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0002244	Abnormality of the small intestine	3	204	1.42	0.0070	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000418960	BMPR1A,FANCA,BRCA1
Monarch	HP:0001770	Toe syndactyly	3	206	1.42	0.0071	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0000133	Gonadal dysgenesis	2	35	2.01	0.0073	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0002591	Polyphagia	2	35	2.01	0.0073	9606.ENSP00000360141,9606.ENSP00000386759	GNAS,SETD2
Monarch	HP:0003003	Colon cancer	2	35	2.01	0.0073	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0007874	Almond-shaped palpebral fissure	2	35	2.01	0.0073	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0011563	Abnormal ventriculoarterial connection	3	208	1.41	0.0073	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960	WT1,FANCA,BRCA1
Monarch	HP:0005374	Cellular immunodeficiency	2	38	1.97	0.0082	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0001780	Abnormality of toe	4	588	1.09	0.0084	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,FANCA,SETD2,BRCA1
Monarch	HP:0005918	Abnormal finger phalanx morphology	4	589	1.08	0.0084	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000498881	GNAS,FANCA,SETD2,ERCC5
Monarch	HP:0001396	Cholestasis	3	223	1.38	0.0085	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000386759	TP53,GNAS,SETD2
Monarch	HP:0008214	Decreased serum estradiol	2	39	1.96	0.0085	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0200006	Slanting of the palpebral fissure	4	599	1.08	0.0089	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	BMPR1A,FANCA,SETD2,BRCA1
Monarch	HP:0000163	Abnormal oral cavity morphology	6	1901	0.75	0.0090	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0001537	Umbilical hernia	3	228	1.37	0.0090	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0003026	Short long bone	3	229	1.37	0.0090	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	GNAS,FANCA,BRCA1
Monarch	HP:0000037	Male pseudohermaphroditism	2	41	1.94	0.0091	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0010741	Pedal edema	2	41	1.94	0.0091	9606.ENSP00000269305,9606.ENSP00000386759	TP53,SETD2
Monarch	HP:0030065	Primitive neuroectodermal tumor	2	41	1.94	0.0091	9606.ENSP00000269305,9606.ENSP00000386759	TP53,SETD2
Monarch	HP:0000598	Abnormality of the ear	6	1919	0.75	0.0092	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0012758	Neurodevelopmental delay	6	1926	0.75	0.0093	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0001551	Abnormal umbilicus morphology	3	235	1.36	0.0094	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0001289	Confusion	2	43	1.92	0.0098	9606.ENSP00000360141,9606.ENSP00000498881	GNAS,ERCC5
Monarch	HP:0000483	Astigmatism	3	239	1.35	0.0099	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0000568	Microphthalmia	3	239	1.35	0.0099	9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	FANCA,BRCA1,ERCC5
Monarch	HP:0012740	Papilloma	2	45	1.9	0.0105	9606.ENSP00000269305,9606.ENSP00000498881	TP53,ERCC5
Monarch	HP:0100012	Neoplasm of the eye	2	45	1.9	0.0105	9606.ENSP00000269305,9606.ENSP00000498881	TP53,ERCC5
Monarch	EFO:0004872	Inflammatory biomarker measurement	5	1226	0.86	0.0109	9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759	ATM,WT1,FANCA,MAP3K1,SETD2
Monarch	HP:0002997	Obsolete Abnormality of the ulna	2	46	1.89	0.0109	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0000086	Ectopic kidney	2	47	1.88	0.0113	9606.ENSP00000368370,9606.ENSP00000373952	WT1,FANCA
Monarch	HP:0005105	Abnormal nasal morphology	5	1245	0.86	0.0116	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,BMPR1A,SETD2,BRCA1,ERCC5
Monarch	HP:0000925	Abnormality of the vertebral column	5	1252	0.85	0.0118	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0001760	Abnormal foot morphology	5	1253	0.85	0.0118	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000813	Bicornuate uterus	2	49	1.86	0.0120	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0002756	Pathologic fracture	2	49	1.86	0.0120	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Monarch	HP:0008678	Renal hypoplasia/aplasia	3	264	1.31	0.0125	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	EFO:0004308	Leukocyte count	6	2057	0.72	0.0126	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,BMPR1A,FANCA,SETD2,BRCA1
Monarch	HP:0011314	Abnormal long bone morphology	4	675	1.03	0.0126	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	TP53,GNAS,FANCA,BRCA1
Monarch	HP:0003072	Hypercalcemia	2	51	1.85	0.0127	9606.ENSP00000269305,9606.ENSP00000386759	TP53,SETD2
Monarch	HP:0000365	Hearing impairment	5	1288	0.84	0.0131	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0000837	Increased circulating gonadotropin level	2	52	1.84	0.0131	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0002890	Thyroid carcinoma	2	52	1.84	0.0131	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0006824	Cranial nerve paralysis	3	271	1.3	0.0131	9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960	WT1,FANCA,BRCA1
Monarch	HP:0007364	Aplasia/Hypoplasia of the cerebrum	5	1300	0.84	0.0135	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0003022	Hypoplasia of the ulna	2	54	1.82	0.0138	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0005607	Abnormal tracheobronchial morphology	3	278	1.29	0.0140	9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000418960	ATM,FANCA,BRCA1
Monarch	HP:0008047	Abnormality of the vasculature of the eye	3	279	1.28	0.0141	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000498881	ATM,GNAS,ERCC5
Monarch	HP:0002750	Delayed skeletal maturation	3	280	1.28	0.0142	9606.ENSP00000269305,9606.ENSP00000382423,9606.ENSP00000498881	TP53,MAP3K1,ERCC5
Monarch	HP:0031703	Abnormal ear morphology	5	1320	0.83	0.0142	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	BMPR1A,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0100585	Telangiectasia of the skin	2	55	1.81	0.0142	9606.ENSP00000278616,9606.ENSP00000498881	ATM,ERCC5
Monarch	HP:0002245	Meckel diverticulum	2	56	1.81	0.0144	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0025615	Abscess	2	56	1.81	0.0144	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0410042	Abnormal liver morphology	4	715	1.0	0.0147	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370	TP53,GNAS,BMPR1A,WT1
Monarch	HP:0005344	Abnormal carotid artery morphology	2	57	1.8	0.0148	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0002719	Recurrent infections	4	721	1.0	0.0151	9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	ATM,FANCA,SETD2,BRCA1
Monarch	HP:0005616	Accelerated skeletal maturation	2	58	1.79	0.0152	9606.ENSP00000360141,9606.ENSP00000386759	GNAS,SETD2
Monarch	HP:0002167	Neurological speech impairment	5	1354	0.82	0.0155	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,GNAS,SETD2,BRCA1,ERCC5
Monarch	HP:0031704	Abnormal ear physiology	5	1362	0.82	0.0158	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,SETD2,BRCA1,ERCC5
Monarch	EFO:0004842	Eosinophil count	4	734	0.99	0.0159	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,SETD2,BRCA1
Monarch	HP:0008070	Sparse hair	3	300	1.25	0.0164	9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	MAP3K1,SETD2,BRCA1
Monarch	HP:0001873	Thrombocytopenia	3	305	1.25	0.0172	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000418960	TP53,FANCA,BRCA1
Monarch	HP:0001409	Portal hypertension	2	63	1.75	0.0174	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0002039	Anorexia	2	63	1.75	0.0174	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0001763	Pes planus	3	308	1.24	0.0175	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0001199	Triphalangeal thumb	2	64	1.75	0.0178	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0002575	Tracheoesophageal fistula	2	65	1.74	0.0183	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0006265	Aplasia/Hypoplasia of fingers	3	315	1.23	0.0185	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	GNAS,FANCA,BRCA1
Monarch	HP:0003073	Hypoalbuminemia	2	66	1.73	0.0187	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0100691	Abnormality of the curvature of the cornea	3	317	1.23	0.0187	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0002900	Hypokalemia	2	67	1.73	0.0191	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0012116	Abnormal circulating albumin concentration	2	67	1.73	0.0191	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0001197	Abnormality of prenatal development or birth	4	786	0.96	0.0196	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	TP53,FANCA,BRCA1,ERCC5
Monarch	HP:0011873	Abnormal platelet count	3	323	1.22	0.0196	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000418960	TP53,FANCA,BRCA1
Monarch	HP:0000072	Hydroureter	2	69	1.72	0.0200	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0030087	Abnormal circulating testosterone concentration	2	69	1.72	0.0200	9606.ENSP00000360141,9606.ENSP00000382423	GNAS,MAP3K1
Monarch	EFO:0004503	Hematological measurement	8	4592	0.49	0.0207	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,SETD2,BRCA1
Monarch	HP:0002653	Bone pain	2	73	1.69	0.0219	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Monarch	HP:0100749	Chest pain	2	73	1.69	0.0219	9606.ENSP00000360141,9606.ENSP00000368370	GNAS,WT1
Monarch	HP:0012115	Hepatitis	2	74	1.68	0.0223	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Monarch	HP:0000164	Abnormality of the dentition	4	821	0.94	0.0224	9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,SETD2,BRCA1,ERCC5
Monarch	HP:0000819	Diabetes mellitus	3	350	1.19	0.0235	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141	TP53,ATM,GNAS
Monarch	HP:0002094	Dyspnea	3	350	1.19	0.0235	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370	TP53,GNAS,WT1
Monarch	HP:0003011	Abnormality of the musculature	6	2384	0.65	0.0235	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,WT1,SETD2,ERCC5
Monarch	HP:0001159	Syndactyly	3	351	1.18	0.0236	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0012719	Functional abnormality of the gastrointestinal tract	4	840	0.93	0.0238	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000386759	GNAS,BMPR1A,WT1,SETD2
Monarch	HP:0000277	Abnormal mandible morphology	4	841	0.93	0.0239	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0007759	Opacification of the corneal stroma	2	78	1.66	0.0240	9606.ENSP00000360141,9606.ENSP00000498881	GNAS,ERCC5
Monarch	HP:0001376	Limitation of joint mobility	3	356	1.18	0.0242	9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000498881	GNAS,SETD2,ERCC5
Monarch	HP:0011805	Abnormal skeletal muscle morphology	5	1537	0.77	0.0244	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000498881	ATM,GNAS,WT1,SETD2,ERCC5
Monarch	HP:0000963	Thin skin	2	80	1.65	0.0248	9606.ENSP00000360141,9606.ENSP00000498881	GNAS,ERCC5
Monarch	HP:0011732	Abnormality of adrenal morphology	2	80	1.65	0.0248	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Monarch	HP:0006501	Aplasia/Hypoplasia of the radius	2	81	1.65	0.0252	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0010622	Neoplasm of the skeletal system	2	81	1.65	0.0252	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
Monarch	HP:0001263	Global developmental delay	5	1559	0.76	0.0257	9606.ENSP00000269305,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,FANCA,SETD2,BRCA1,ERCC5
Monarch	HP:0005922	Abnormal hand morphology	4	870	0.92	0.0263	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,FANCA,SETD2,BRCA1
Monarch	HP:0010866	Abdominal wall defect	3	375	1.16	0.0273	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	FANCA,SETD2,BRCA1
Monarch	HP:0008572	External ear malformation	2	86	1.62	0.0279	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0000085	Horseshoe kidney	2	87	1.61	0.0284	9606.ENSP00000368370,9606.ENSP00000373952	WT1,FANCA
Monarch	HP:0000422	Abnormal nasal bridge morphology	4	897	0.9	0.0290	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,BMPR1A,BRCA1,ERCC5
Monarch	HP:0001250	Seizure	5	1607	0.75	0.0290	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,SETD2,ERCC5
Monarch	HP:0004334	Dermal atrophy	2	88	1.61	0.0290	9606.ENSP00000360141,9606.ENSP00000498881	GNAS,ERCC5
Monarch	HP:0001882	Leukopenia	2	90	1.6	0.0301	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0002650	Scoliosis	4	908	0.9	0.0301	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	GNAS,FANCA,SETD2,BRCA1
Monarch	HP:0009778	Short thumb	2	91	1.6	0.0305	9606.ENSP00000360141,9606.ENSP00000373952	GNAS,FANCA
Monarch	HP:0004207	Abnormal 5th finger morphology	3	396	1.13	0.0311	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	GNAS,FANCA,BRCA1
Monarch	HP:0040070	Abnormal upper limb bone morphology	3	401	1.13	0.0321	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960	GNAS,FANCA,BRCA1
Monarch	HP:0002414	Spina bifida	2	94	1.58	0.0322	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0004305	Involuntary movements	4	933	0.89	0.0327	9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000498881	ATM,GNAS,SETD2,ERCC5
Monarch	HP:0001266	Choreoathetosis	2	96	1.57	0.0334	9606.ENSP00000278616,9606.ENSP00000360141	ATM,GNAS
Monarch	EFO:0010701	Mean reticulocyte volume	3	409	1.12	0.0336	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370	TP53,ATM,WT1
Monarch	HP:0000010	Recurrent urinary tract infections	2	99	1.56	0.0351	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0011042	Abnormal blood potassium concentration	2	99	1.56	0.0351	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0011442	Abnormal central motor function	5	1689	0.72	0.0351	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,SETD2,ERCC5
Monarch	HP:0000786	Primary amenorrhea	2	100	1.55	0.0356	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0000453	Choanal atresia	2	101	1.55	0.0362	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0001876	Pancytopenia	2	102	1.55	0.0368	9606.ENSP00000360141,9606.ENSP00000373952	GNAS,FANCA
Monarch	HP:0000689	Dental malocclusion	2	104	1.54	0.0381	9606.ENSP00000360141,9606.ENSP00000418960	GNAS,BRCA1
Monarch	HP:0030448	Soft tissue sarcoma	2	104	1.54	0.0381	9606.ENSP00000269305,9606.ENSP00000361107	TP53,BMPR1A
Monarch	HP:0009115	Aplasia/hypoplasia involving the skeleton	4	985	0.86	0.0389	9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	GNAS,FANCA,BRCA1,ERCC5
Monarch	HP:0000062	Ambiguous genitalia	2	106	1.53	0.0393	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0003251	Male infertility	2	110	1.51	0.0419	9606.ENSP00000373952,9606.ENSP00000382423	FANCA,MAP3K1
Monarch	HP:0040202	Abnormal consumption behavior	2	111	1.51	0.0424	9606.ENSP00000360141,9606.ENSP00000386759	GNAS,SETD2
Monarch	HP:0000050	Hypoplastic male external genitalia	3	452	1.08	0.0429	9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000498881	WT1,MAP3K1,ERCC5
Monarch	HP:0000377	Abnormal pinna morphology	4	1019	0.85	0.0431	9606.ENSP00000361107,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000498881	BMPR1A,FANCA,BRCA1,ERCC5
Monarch	HP:0002023	Anal atresia	2	113	1.5	0.0435	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0011733	Abnormality of adrenal physiology	2	113	1.5	0.0435	9606.ENSP00000360141,9606.ENSP00000382423	GNAS,MAP3K1
Monarch	HP:0001646	Abnormal aortic valve morphology	2	116	1.49	0.0454	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
Monarch	HP:0000100	Nephrotic syndrome	2	117	1.49	0.0460	9606.ENSP00000368370,9606.ENSP00000382423	WT1,MAP3K1
Monarch	HP:0010876	Abnormal circulating protein concentration	3	466	1.06	0.0460	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000361107	TP53,ATM,BMPR1A
Monarch	HP:0000708	Behavioral abnormality	5	1839	0.69	0.0486	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000498881	TP53,ATM,GNAS,SETD2,ERCC5
Monarch	HP:0002514	Cerebral calcification	2	122	1.47	0.0496	9606.ENSP00000360141,9606.ENSP00000498881	GNAS,ERCC5
Monarch	HP:0034221	Abnormal temporal lobe morphology	2	122	1.47	0.0496	9606.ENSP00000360141,9606.ENSP00000498881	GNAS,ERCC5
DISEASES	DOID:3114	Serous cystadenocarcinoma	3	5	3.03	3.32e-05	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000418960	TP53,WT1,BRCA1
DISEASES	DOID:0050686	Organ system cancer	7	757	1.22	3.56e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,WT1,MAP3K1,SETD2,BRCA1
DISEASES	DOID:1612	Breast cancer	4	62	2.06	3.56e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000382423,9606.ENSP00000418960	TP53,ATM,MAP3K1,BRCA1
DISEASES	DOID:225	Syndrome	8	1214	1.07	3.56e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,BRCA1,BIVM-ERCC5,ERCC5
DISEASES	DOID:0050687	Cell type cancer	6	451	1.38	3.59e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,GNAS,WT1,SETD2,BRCA1
DISEASES	DOID:3996	Urinary system cancer	4	89	1.91	6.24e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000386759	TP53,ATM,WT1,SETD2
DISEASES	DOID:3459	Breast carcinoma	3	29	2.27	0.00019	9606.ENSP00000269305,9606.ENSP00000382423,9606.ENSP00000418960	TP53,MAP3K1,BRCA1
DISEASES	DOID:0050739	Autosomal genetic disease	9	2802	0.76	0.00029	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,BRCA1,BIVM-ERCC5,ERCC5
DISEASES	DOID:4947	Cholangiocarcinoma	3	40	2.13	0.00043	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000418960	TP53,GNAS,BRCA1
DISEASES	DOID:229	Female reproductive system disease	4	192	1.57	0.00062	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000418960	TP53,ATM,WT1,BRCA1
DISEASES	DOID:263	Kidney cancer	3	51	2.02	0.00063	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000386759	TP53,WT1,SETD2
DISEASES	DOID:4	Disease	11	6291	0.5	0.00068	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,BIVM-ERCC5,ERCC5
DISEASES	DOID:12704	Ataxia telangiectasia	2	5	2.86	0.0010	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
DISEASES	DOID:3008	Invasive ductal carcinoma	2	5	2.86	0.0010	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
DISEASES	DOID:7	Disease of anatomical entity	10	4798	0.57	0.0010	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,MAP3K1,SETD2,BRCA1,ERCC5
DISEASES	DOID:3012	Li-Fraumeni syndrome	2	6	2.78	0.0012	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
DISEASES	DOID:345	Uterine disease	3	72	1.87	0.0012	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370	TP53,ATM,WT1
DISEASES	DOID:0110849	Xeroderma pigmentosum group G	2	10	2.55	0.0023	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
DISEASES	DOID:305	Carcinoma	4	307	1.37	0.0023	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000386759,9606.ENSP00000418960	TP53,GNAS,SETD2,BRCA1
DISEASES	DOID:2154	Nephroblastoma	2	12	2.47	0.0030	9606.ENSP00000269305,9606.ENSP00000368370	TP53,WT1
DISEASES	DOID:8719	In situ carcinoma	2	13	2.44	0.0034	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
DISEASES	DOID:4001	Ovarian carcinoma	2	16	2.35	0.0046	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
DISEASES	DOID:1795	Tumor of exocrine pancreas	2	17	2.32	0.0049	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
DISEASES	DOID:28	Endocrine system disease	4	398	1.26	0.0050	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000382423,9606.ENSP00000418960	TP53,GNAS,MAP3K1,BRCA1
DISEASES	DOID:0060086	Female reproductive organ benign neoplasm	2	25	2.16	0.0089	9606.ENSP00000269305,9606.ENSP00000368370	TP53,WT1
DISEASES	DOID:13636	Fanconi anemia	2	25	2.16	0.0089	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
DISEASES	DOID:193	Reproductive organ cancer	3	167	1.51	0.0089	9606.ENSP00000269305,9606.ENSP00000368370,9606.ENSP00000418960	TP53,WT1,BRCA1
DISEASES	DOID:2277	Gonadal disease	3	186	1.46	0.0111	9606.ENSP00000269305,9606.ENSP00000382423,9606.ENSP00000418960	TP53,MAP3K1,BRCA1
DISEASES	DOID:0050737	Autosomal recessive disease	6	1785	0.78	0.0137	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000373952,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,GNAS,FANCA,BIVM-ERCC5,ERCC5
DISEASES	DOID:5295	Intestinal disease	3	216	1.4	0.0162	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107	TP53,GNAS,BMPR1A
DISEASES	DOID:77	Gastrointestinal system disease	4	576	1.09	0.0162	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000418960	TP53,GNAS,BMPR1A,BRCA1
DISEASES	DOID:11054	Urinary bladder cancer	2	38	1.97	0.0164	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
DISEASES	DOID:0060085	Organ system benign neoplasm	3	237	1.36	0.0200	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000368370	TP53,GNAS,WT1
DISEASES	DOID:1909	Melanoma	2	46	1.89	0.0226	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
DISEASES	DOID:9553	Adrenal gland disease	2	46	1.89	0.0226	9606.ENSP00000269305,9606.ENSP00000360141	TP53,GNAS
DISEASES	DOID:10283	Prostate cancer	2	52	1.84	0.0274	9606.ENSP00000368370,9606.ENSP00000418960	WT1,BRCA1
DISEASES	DOID:0050736	Autosomal dominant disease	5	1386	0.81	0.0353	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000418960	TP53,GNAS,BMPR1A,WT1,BRCA1
DISEASES	DOID:4159	Skin cancer	2	63	1.75	0.0359	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
DISEASES	DOID:1115	Sarcoma	2	73	1.69	0.0453	9606.ENSP00000269305,9606.ENSP00000368370	TP53,WT1
TISSUES	BTO:0001541	Pronephros	5	219	1.61	0.00019	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960	TP53,ATM,WT1,FANCA,BRCA1
TISSUES	BTO:0004483	Ovarian surface epithelium	2	3	3.08	0.0034	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
TISSUES	BTO:0001938	U2-OS cell	2	5	2.86	0.0036	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
TISSUES	BTO:0002072	Squamous epithelium	2	10	2.55	0.0090	9606.ENSP00000269305,9606.ENSP00000368370	TP53,WT1
TISSUES	BTO:0000174	Embryonic structure	7	2369	0.72	0.0197	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000418960	TP53,ATM,GNAS,BMPR1A,WT1,FANCA,BRCA1
TISSUES	BTO:0000356	Breast cancer cell line	2	35	2.01	0.0377	9606.ENSP00000269305,9606.ENSP00000418960	TP53,BRCA1
COMPARTMENTS	GOCC:1990391	DNA repair complex	4	53	2.13	4.70e-05	9606.ENSP00000278616,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	ATM,BRCA1,BIVM-ERCC5,ERCC5
COMPARTMENTS	GOCC:0005654	Nucleoplasm	6	1146	0.97	0.0162	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,WT1,FANCA,SETD2,BRCA1
COMPARTMENTS	GOCC:0071942	XPC complex	2	10	2.55	0.0162	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
COMPARTMENTS	GOCC:0030870	Mre11 complex	2	15	2.38	0.0221	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
COMPARTMENTS	GOCC:0070419	Nonhomologous end joining complex	2	16	2.35	0.0221	9606.ENSP00000278616,9606.ENSP00000418960	ATM,BRCA1
COMPARTMENTS	GOCC:0005634	Nucleus	9	4787	0.53	0.0328	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000360141,9606.ENSP00000368370,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000491742,9606.ENSP00000498881	TP53,ATM,GNAS,WT1,FANCA,SETD2,BRCA1,BIVM-ERCC5,ERCC5
UniProt Keywords	KW-0043	Tumor suppressor	5	177	1.7	1.89e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000368370,9606.ENSP00000386759,9606.ENSP00000418960	TP53,ATM,WT1,SETD2,BRCA1
UniProt Keywords	KW-0227	DNA damage	5	386	1.37	0.00042	9606.ENSP00000278616,9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	ATM,FANCA,SETD2,BRCA1,ERCC5
UniProt Keywords	KW-0234	DNA repair	4	325	1.34	0.0051	9606.ENSP00000373952,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	FANCA,SETD2,BRCA1,ERCC5
UniProt Keywords	KW-0923	Fanconi anemia	2	21	2.23	0.0120	9606.ENSP00000373952,9606.ENSP00000418960	FANCA,BRCA1
UniProt Keywords	KW-0479	Metal-binding	8	3702	0.59	0.0201	9606.ENSP00000269305,9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000368370,9606.ENSP00000382423,9606.ENSP00000386759,9606.ENSP00000418960,9606.ENSP00000498881	TP53,GNAS,BMPR1A,WT1,MAP3K1,SETD2,BRCA1,ERCC5
UniProt Keywords	KW-0460	Magnesium	4	578	1.09	0.0236	9606.ENSP00000360141,9606.ENSP00000361107,9606.ENSP00000382423,9606.ENSP00000498881	GNAS,BMPR1A,MAP3K1,ERCC5
InterPro	IPR001044	XPG/Rad2 endonuclease, eukaryotes	2	2	3.25	0.0122	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
InterPro	IPR006084	XPG/Rad2 endonuclease	2	5	2.86	0.0152	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
InterPro	IPR006085	XPG, N-terminal	2	6	2.78	0.0152	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
InterPro	IPR006086	XPG-I domain	2	5	2.86	0.0152	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
InterPro	IPR008918	Helix-hairpin-helix motif, class 2	2	5	2.86	0.0152	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
InterPro	IPR019974	XPG conserved site	2	4	2.95	0.0152	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
InterPro	IPR036279	5-3 exonuclease, C-terminal domain superfamily	2	5	2.86	0.0152	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
InterPro	IPR029060	PIN-like domain superfamily	2	14	2.41	0.0304	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
SMART	SM00279	Helix-hairpin-helix class 2 (Pol1 family) motifs	2	5	2.86	0.0049	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
SMART	SM00484	Xeroderma pigmentosum G I-region	2	5	2.86	0.0049	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
SMART	SM00485	Xeroderma pigmentosum G N-region	2	5	2.86	0.0049	9606.ENSP00000491742,9606.ENSP00000498881	BIVM-ERCC5,ERCC5
